Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anti-Bacterial Agents | 116 | 2022 | 7153 | 3.440 |
Why?
|
Vancomycin | 46 | 2009 | 500 | 3.210 |
Why?
|
Staphylococcus aureus | 33 | 2015 | 1449 | 2.670 |
Why?
|
Vancomycin Resistance | 19 | 2012 | 128 | 2.570 |
Why?
|
Gram-Positive Bacterial Infections | 26 | 2009 | 341 | 2.350 |
Why?
|
Microbial Sensitivity Tests | 110 | 2018 | 1871 | 2.180 |
Why?
|
Enterococcus | 17 | 2015 | 158 | 1.960 |
Why?
|
Gram-Positive Bacteria | 21 | 2005 | 184 | 1.910 |
Why?
|
Daptomycin | 16 | 2015 | 73 | 1.900 |
Why?
|
Oxazolidinones | 13 | 2007 | 96 | 1.690 |
Why?
|
Enterococcus faecium | 14 | 2009 | 102 | 1.560 |
Why?
|
Staphylococcal Infections | 22 | 2012 | 1398 | 1.490 |
Why?
|
Methicillin Resistance | 18 | 2006 | 198 | 1.430 |
Why?
|
Endocarditis, Bacterial | 22 | 2008 | 453 | 1.420 |
Why?
|
Acetamides | 12 | 2007 | 249 | 1.400 |
Why?
|
Anti-Infective Agents | 17 | 2021 | 971 | 1.390 |
Why?
|
Drug Resistance, Bacterial | 14 | 2015 | 1032 | 1.280 |
Why?
|
Enterococcus faecalis | 30 | 2004 | 251 | 1.170 |
Why?
|
Virginiamycin | 7 | 2004 | 11 | 1.060 |
Why?
|
Fluoroquinolones | 13 | 2022 | 308 | 0.950 |
Why?
|
Drug Resistance, Microbial | 56 | 2001 | 860 | 0.940 |
Why?
|
Gentamicins | 18 | 2017 | 253 | 0.860 |
Why?
|
Aminoglycosides | 11 | 2009 | 161 | 0.790 |
Why?
|
Pseudomonas aeruginosa | 10 | 2020 | 1210 | 0.780 |
Why?
|
Teicoplanin | 8 | 2009 | 27 | 0.750 |
Why?
|
Fosfomycin | 4 | 2016 | 25 | 0.720 |
Why?
|
Streptococcus | 17 | 1999 | 197 | 0.680 |
Why?
|
Cephalosporins | 14 | 2020 | 203 | 0.660 |
Why?
|
RNA, Ribosomal, 23S | 5 | 2007 | 53 | 0.630 |
Why?
|
Bacteria | 25 | 2001 | 2102 | 0.610 |
Why?
|
beta-Lactamases | 20 | 2022 | 303 | 0.600 |
Why?
|
Enterobacteriaceae | 9 | 2015 | 169 | 0.590 |
Why?
|
Bacterial Proteins | 27 | 2015 | 3843 | 0.570 |
Why?
|
Oxacillin | 7 | 2009 | 42 | 0.550 |
Why?
|
Drug Resistance, Multiple, Bacterial | 8 | 2018 | 563 | 0.530 |
Why?
|
Cystitis | 1 | 2015 | 92 | 0.520 |
Why?
|
Bacteriuria | 1 | 2015 | 100 | 0.510 |
Why?
|
Ketolides | 3 | 1998 | 12 | 0.480 |
Why?
|
Ciprofloxacin | 9 | 2016 | 314 | 0.480 |
Why?
|
Streptococcus pneumoniae | 3 | 2006 | 712 | 0.460 |
Why?
|
Drug Therapy, Combination | 23 | 2003 | 6483 | 0.460 |
Why?
|
Quinolones | 5 | 2004 | 366 | 0.440 |
Why?
|
Acinetobacter baumannii | 4 | 2018 | 107 | 0.430 |
Why?
|
Macrolides | 3 | 1998 | 201 | 0.430 |
Why?
|
Bacteremia | 6 | 2007 | 962 | 0.420 |
Why?
|
Quinolines | 6 | 1998 | 719 | 0.420 |
Why?
|
Erythromycin | 7 | 2003 | 120 | 0.410 |
Why?
|
Ampicillin | 13 | 2016 | 138 | 0.390 |
Why?
|
Acinetobacter | 3 | 2008 | 39 | 0.380 |
Why?
|
Staphylococcus | 8 | 2000 | 155 | 0.380 |
Why?
|
Penicillins | 14 | 2001 | 378 | 0.370 |
Why?
|
Pseudomonas Infections | 2 | 2020 | 608 | 0.370 |
Why?
|
Methicillin | 4 | 2007 | 59 | 0.370 |
Why?
|
Drug Synergism | 27 | 2009 | 1791 | 0.350 |
Why?
|
Operon | 2 | 2007 | 360 | 0.350 |
Why?
|
Acinetobacter Infections | 2 | 2009 | 69 | 0.340 |
Why?
|
Peptide Nucleic Acids | 1 | 2008 | 24 | 0.330 |
Why?
|
Oxazoles | 4 | 1999 | 189 | 0.330 |
Why?
|
Aza Compounds | 2 | 1998 | 32 | 0.320 |
Why?
|
Nebramycin | 2 | 2018 | 10 | 0.310 |
Why?
|
Penicillanic Acid | 4 | 1997 | 44 | 0.290 |
Why?
|
Abdominal Abscess | 2 | 1999 | 154 | 0.290 |
Why?
|
Glycopeptides | 8 | 2004 | 224 | 0.290 |
Why?
|
Genome, Bacterial | 1 | 2012 | 754 | 0.290 |
Why?
|
Streptococcal Infections | 14 | 1991 | 637 | 0.290 |
Why?
|
Piperacillin | 4 | 1997 | 40 | 0.290 |
Why?
|
Legionella | 2 | 1998 | 30 | 0.280 |
Why?
|
Trans-Activators | 6 | 2006 | 2924 | 0.280 |
Why?
|
Minocycline | 2 | 2000 | 163 | 0.280 |
Why?
|
Nitrofurantoin | 2 | 2016 | 19 | 0.280 |
Why?
|
Cross Infection | 11 | 2009 | 1413 | 0.280 |
Why?
|
Hexosyltransferases | 8 | 2001 | 53 | 0.280 |
Why?
|
Peptidyl Transferases | 8 | 2001 | 54 | 0.280 |
Why?
|
RNA, Bacterial | 2 | 2007 | 391 | 0.270 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2009 | 687 | 0.270 |
Why?
|
Penicillin Resistance | 12 | 2000 | 83 | 0.270 |
Why?
|
Streptogramins | 1 | 2005 | 1 | 0.270 |
Why?
|
Bacterial Infections | 15 | 1999 | 1389 | 0.260 |
Why?
|
Genes, rRNA | 2 | 2004 | 70 | 0.250 |
Why?
|
DNA Topoisomerase IV | 1 | 2004 | 40 | 0.250 |
Why?
|
Lactams | 7 | 1996 | 155 | 0.230 |
Why?
|
DNA Gyrase | 1 | 2004 | 82 | 0.230 |
Why?
|
Stenotrophomonas maltophilia | 2 | 2000 | 16 | 0.230 |
Why?
|
Depsipeptides | 2 | 2002 | 94 | 0.230 |
Why?
|
Gram-Negative Bacteria | 6 | 1999 | 270 | 0.220 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2008 | 2638 | 0.210 |
Why?
|
Peptides, Cyclic | 3 | 2002 | 401 | 0.210 |
Why?
|
Cefotaxime | 3 | 1989 | 35 | 0.210 |
Why?
|
Pneumococcal Infections | 1 | 2006 | 496 | 0.200 |
Why?
|
Moths | 3 | 2015 | 85 | 0.200 |
Why?
|
Digestive System | 1 | 2002 | 251 | 0.190 |
Why?
|
Sulbactam | 5 | 2001 | 26 | 0.190 |
Why?
|
Thiadiazines | 1 | 2000 | 10 | 0.190 |
Why?
|
Tobramycin | 3 | 2017 | 69 | 0.180 |
Why?
|
Methyltransferases | 1 | 2003 | 367 | 0.180 |
Why?
|
Taurine | 1 | 2000 | 94 | 0.180 |
Why?
|
Thienamycins | 5 | 1993 | 27 | 0.170 |
Why?
|
Imipenem | 5 | 1993 | 37 | 0.170 |
Why?
|
Substance Abuse Detection | 1 | 2001 | 283 | 0.170 |
Why?
|
Amikacin | 2 | 2017 | 48 | 0.170 |
Why?
|
Carrier State | 2 | 2002 | 518 | 0.160 |
Why?
|
Trimethoprim | 1 | 1997 | 91 | 0.150 |
Why?
|
Humans | 117 | 2020 | 742088 | 0.150 |
Why?
|
Corynebacterium | 3 | 1992 | 47 | 0.150 |
Why?
|
Thigh | 1 | 2018 | 247 | 0.140 |
Why?
|
Mutation | 8 | 2008 | 29717 | 0.140 |
Why?
|
Ofloxacin | 1 | 1996 | 65 | 0.140 |
Why?
|
Klebsiella Infections | 1 | 1997 | 137 | 0.140 |
Why?
|
Quinolizines | 1 | 1995 | 19 | 0.130 |
Why?
|
Ceftazidime | 4 | 2020 | 68 | 0.130 |
Why?
|
Drug Antagonism | 4 | 2009 | 50 | 0.130 |
Why?
|
Cell Wall | 4 | 2012 | 422 | 0.130 |
Why?
|
History, 20th Century | 2 | 2021 | 2739 | 0.130 |
Why?
|
Tetracyclines | 1 | 1994 | 60 | 0.120 |
Why?
|
Cefoperazone | 3 | 1989 | 7 | 0.120 |
Why?
|
Microbiology | 1 | 2014 | 72 | 0.120 |
Why?
|
Culture Media | 6 | 2001 | 902 | 0.120 |
Why?
|
Abscess | 6 | 1994 | 607 | 0.110 |
Why?
|
Bacteriolysis | 4 | 2009 | 51 | 0.110 |
Why?
|
Naphthyridines | 2 | 1993 | 118 | 0.110 |
Why?
|
Genes, Bacterial | 4 | 2004 | 1078 | 0.110 |
Why?
|
beta-Lactams | 7 | 1991 | 159 | 0.110 |
Why?
|
Corynebacterium Infections | 1 | 1992 | 27 | 0.110 |
Why?
|
Aminoacyltransferases | 2 | 2015 | 51 | 0.100 |
Why?
|
Rats | 20 | 2003 | 24265 | 0.100 |
Why?
|
Virulence | 6 | 2015 | 1328 | 0.100 |
Why?
|
Streptomycin | 3 | 1990 | 69 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 8 | 2003 | 8300 | 0.100 |
Why?
|
Sequence Analysis, DNA | 6 | 2012 | 4801 | 0.100 |
Why?
|
Hemolysin Proteins | 3 | 2006 | 113 | 0.100 |
Why?
|
Blood | 3 | 2004 | 598 | 0.100 |
Why?
|
Drug Combinations | 6 | 2020 | 1961 | 0.090 |
Why?
|
Carbapenems | 3 | 2000 | 117 | 0.090 |
Why?
|
Ampicillin Resistance | 1 | 2009 | 11 | 0.090 |
Why?
|
Laboratories, Hospital | 1 | 2012 | 194 | 0.090 |
Why?
|
Pyridones | 1 | 1995 | 712 | 0.090 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2012 | 337 | 0.090 |
Why?
|
Clindamycin | 4 | 1997 | 139 | 0.090 |
Why?
|
Microbial Viability | 2 | 2009 | 234 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 1997 | 959 | 0.090 |
Why?
|
Urinary Tract Infections | 1 | 2016 | 786 | 0.090 |
Why?
|
Animals | 36 | 2018 | 168561 | 0.090 |
Why?
|
Aztreonam | 1 | 1989 | 12 | 0.090 |
Why?
|
Giardiasis | 1 | 1989 | 28 | 0.090 |
Why?
|
Urinary Bladder | 1 | 2015 | 1171 | 0.080 |
Why?
|
Polymerase Chain Reaction | 6 | 2004 | 6171 | 0.080 |
Why?
|
Muramoylpentapeptide Carboxypeptidase | 8 | 2001 | 26 | 0.080 |
Why?
|
DNA, Bacterial | 8 | 2004 | 1465 | 0.080 |
Why?
|
Molecular Sequence Data | 9 | 2002 | 18112 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 1997 | 3800 | 0.080 |
Why?
|
Drug Resistance, Multiple | 2 | 1999 | 252 | 0.080 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 3 | 2004 | 143 | 0.080 |
Why?
|
4-Quinolones | 2 | 2001 | 25 | 0.080 |
Why?
|
Urticaria | 1 | 1989 | 150 | 0.080 |
Why?
|
Novobiocin | 1 | 2007 | 35 | 0.080 |
Why?
|
Myelitis, Transverse | 1 | 1987 | 39 | 0.080 |
Why?
|
Rats, Inbred Strains | 10 | 1992 | 2191 | 0.070 |
Why?
|
Myelitis | 1 | 1987 | 53 | 0.070 |
Why?
|
Korea | 1 | 2006 | 99 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2001 | 2062 | 0.070 |
Why?
|
Ceftriaxone | 2 | 2001 | 168 | 0.070 |
Why?
|
Pharmacy Service, Hospital | 1 | 1987 | 133 | 0.070 |
Why?
|
Peritoneal Diseases | 3 | 1993 | 75 | 0.070 |
Why?
|
Colony Count, Microbial | 2 | 2009 | 331 | 0.070 |
Why?
|
Feces | 2 | 2002 | 1394 | 0.070 |
Why?
|
Candida albicans | 1 | 2008 | 394 | 0.070 |
Why?
|
Genetic Variation | 1 | 2000 | 6540 | 0.060 |
Why?
|
Penicillin-Binding Proteins | 8 | 2001 | 137 | 0.060 |
Why?
|
Patients | 1 | 2012 | 892 | 0.060 |
Why?
|
Adaptation, Biological | 1 | 2006 | 152 | 0.060 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2000 | 232 | 0.060 |
Why?
|
Genotype | 4 | 2015 | 12946 | 0.060 |
Why?
|
Biofilms | 2 | 2008 | 613 | 0.060 |
Why?
|
Metronidazole | 3 | 2002 | 217 | 0.060 |
Why?
|
Intensive Care Units | 3 | 2002 | 3679 | 0.060 |
Why?
|
Models, Biological | 2 | 2012 | 9581 | 0.060 |
Why?
|
Listeria monocytogenes | 2 | 1986 | 250 | 0.060 |
Why?
|
Hemolysis | 3 | 2012 | 420 | 0.060 |
Why?
|
Blood Proteins | 2 | 2005 | 1122 | 0.060 |
Why?
|
Cytomegalovirus Infections | 2 | 1987 | 817 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1887 | 0.060 |
Why?
|
Leukocyte Elastase | 1 | 2003 | 113 | 0.050 |
Why?
|
Intestinal Absorption | 1 | 1984 | 420 | 0.050 |
Why?
|
Klebsiella pneumoniae | 2 | 1997 | 246 | 0.050 |
Why?
|
Pseudomonas | 4 | 1989 | 117 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1792 | 0.050 |
Why?
|
Administration, Oral | 3 | 2005 | 3913 | 0.050 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 1984 | 264 | 0.050 |
Why?
|
Enterobacter | 1 | 2001 | 46 | 0.050 |
Why?
|
Cephalosporin Resistance | 1 | 2001 | 17 | 0.050 |
Why?
|
Peptides | 7 | 1992 | 4392 | 0.050 |
Why?
|
Ribosomes | 2 | 1984 | 499 | 0.050 |
Why?
|
Fever | 1 | 1989 | 1612 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2001 | 192 | 0.050 |
Why?
|
Bacteroides fragilis | 2 | 1993 | 212 | 0.050 |
Why?
|
Serratia marcescens | 1 | 2000 | 45 | 0.050 |
Why?
|
Superinfection | 1 | 2001 | 65 | 0.050 |
Why?
|
Rifampin | 2 | 2003 | 315 | 0.050 |
Why?
|
Male | 38 | 2007 | 349538 | 0.050 |
Why?
|
Host-Pathogen Interactions | 1 | 2009 | 1477 | 0.050 |
Why?
|
Chemokines | 1 | 2004 | 954 | 0.050 |
Why?
|
Azabicyclo Compounds | 1 | 2020 | 68 | 0.040 |
Why?
|
Tetracycline | 1 | 2000 | 214 | 0.040 |
Why?
|
Cross Reactions | 1 | 2001 | 841 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2006 | 13814 | 0.040 |
Why?
|
Urinalysis | 1 | 2001 | 369 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2008 | 1416 | 0.040 |
Why?
|
Time Factors | 9 | 2006 | 40054 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2001 | 981 | 0.040 |
Why?
|
Base Sequence | 5 | 2002 | 12797 | 0.040 |
Why?
|
Bacterial Typing Techniques | 3 | 2009 | 256 | 0.040 |
Why?
|
Hospitals, Veterans | 1 | 2001 | 404 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2001 | 433 | 0.040 |
Why?
|
Pneumonia | 1 | 1990 | 2117 | 0.040 |
Why?
|
Clavulanic Acid | 1 | 1998 | 19 | 0.040 |
Why?
|
Cefuroxime | 1 | 1998 | 23 | 0.040 |
Why?
|
Neutropenia | 1 | 2003 | 891 | 0.040 |
Why?
|
Immunoassay | 1 | 2001 | 752 | 0.040 |
Why?
|
Long-Term Care | 1 | 2001 | 607 | 0.040 |
Why?
|
Enzyme Induction | 2 | 1988 | 475 | 0.040 |
Why?
|
Amoxicillin | 1 | 1998 | 170 | 0.040 |
Why?
|
Phenotype | 4 | 2015 | 16331 | 0.040 |
Why?
|
Kidney Diseases | 1 | 1988 | 2145 | 0.040 |
Why?
|
Area Under Curve | 1 | 2001 | 1653 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2001 | 2335 | 0.040 |
Why?
|
Population Surveillance | 1 | 2006 | 2616 | 0.030 |
Why?
|
Streptococcus pyogenes | 1 | 1998 | 289 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14720 | 0.030 |
Why?
|
Kanamycin | 2 | 1985 | 64 | 0.030 |
Why?
|
Point Mutation | 2 | 2015 | 1624 | 0.030 |
Why?
|
Piperazines | 1 | 1985 | 2488 | 0.030 |
Why?
|
Enterobacteriaceae Infections | 2 | 2001 | 186 | 0.030 |
Why?
|
Gene Deletion | 3 | 2012 | 2751 | 0.030 |
Why?
|
Spleen | 1 | 2001 | 2359 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 1975 | 284 | 0.030 |
Why?
|
Carrier Proteins | 8 | 2001 | 5019 | 0.030 |
Why?
|
Fleroxacin | 1 | 1994 | 13 | 0.030 |
Why?
|
Plasmids | 5 | 1991 | 2305 | 0.030 |
Why?
|
Legionellosis | 1 | 1994 | 11 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8333 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2003 | 2556 | 0.030 |
Why?
|
DNA Primers | 2 | 1999 | 2892 | 0.030 |
Why?
|
Graves Disease | 1 | 1975 | 241 | 0.030 |
Why?
|
Bacteroides Infections | 1 | 1993 | 82 | 0.030 |
Why?
|
Triiodothyronine | 1 | 1975 | 494 | 0.030 |
Why?
|
Adult | 13 | 2008 | 213712 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4328 | 0.030 |
Why?
|
Rifamycins | 1 | 1993 | 25 | 0.030 |
Why?
|
Hyperthyroidism | 1 | 1975 | 293 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2797 | 0.030 |
Why?
|
Abdomen | 3 | 1994 | 1107 | 0.030 |
Why?
|
Larva | 1 | 2015 | 517 | 0.030 |
Why?
|
Drug Interactions | 2 | 2001 | 1458 | 0.030 |
Why?
|
Disease Models, Animal | 8 | 2012 | 18006 | 0.030 |
Why?
|
Female | 19 | 2015 | 379592 | 0.030 |
Why?
|
DNA, Ribosomal | 2 | 2004 | 289 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2004 | 768 | 0.030 |
Why?
|
Glucose | 1 | 2004 | 4391 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 1987 | 4246 | 0.030 |
Why?
|
Lymphoma | 1 | 2001 | 1873 | 0.030 |
Why?
|
Clarithromycin | 2 | 1993 | 86 | 0.030 |
Why?
|
Bacteriological Techniques | 2 | 1990 | 276 | 0.030 |
Why?
|
Liver Abscess | 1 | 2012 | 82 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2006 | 62966 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 3 | 1993 | 2552 | 0.020 |
Why?
|
Drug Utilization | 3 | 2001 | 1181 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2012 | 718 | 0.020 |
Why?
|
Xanthomonas | 1 | 1990 | 18 | 0.020 |
Why?
|
Blood Bactericidal Activity | 2 | 1987 | 126 | 0.020 |
Why?
|
Mycetoma | 1 | 1990 | 12 | 0.020 |
Why?
|
Ticarcillin | 1 | 1989 | 8 | 0.020 |
Why?
|
Clavulanic Acids | 1 | 1989 | 11 | 0.020 |
Why?
|
Costs and Cost Analysis | 2 | 2002 | 1679 | 0.020 |
Why?
|
Octoxynol | 1 | 2009 | 77 | 0.020 |
Why?
|
R Factors | 1 | 1989 | 44 | 0.020 |
Why?
|
Aged | 11 | 2004 | 162944 | 0.020 |
Why?
|
Campylobacter | 1 | 1989 | 59 | 0.020 |
Why?
|
Serum Globulins | 1 | 1989 | 23 | 0.020 |
Why?
|
Helicobacter pylori | 1 | 1993 | 381 | 0.020 |
Why?
|
Cell Cycle | 1 | 1997 | 2964 | 0.020 |
Why?
|
Middle Aged | 14 | 2004 | 213127 | 0.020 |
Why?
|
Farnesol | 1 | 2008 | 20 | 0.020 |
Why?
|
Bacteroides | 1 | 1989 | 161 | 0.020 |
Why?
|
Species Specificity | 1 | 1993 | 2479 | 0.020 |
Why?
|
Imidazoles | 1 | 1995 | 1205 | 0.020 |
Why?
|
Meningitis | 1 | 1990 | 216 | 0.020 |
Why?
|
Virulence Factors | 1 | 2012 | 509 | 0.020 |
Why?
|
Fluorine | 1 | 1988 | 83 | 0.020 |
Why?
|
Quorum Sensing | 1 | 2009 | 131 | 0.020 |
Why?
|
History, 21st Century | 1 | 2014 | 1533 | 0.020 |
Why?
|
Cefaclor | 1 | 1987 | 8 | 0.020 |
Why?
|
Phosphotransferases | 1 | 1988 | 309 | 0.020 |
Why?
|
Cephalexin | 1 | 1987 | 37 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 1988 | 379 | 0.020 |
Why?
|
Conjugation, Genetic | 3 | 1993 | 126 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 1990 | 346 | 0.020 |
Why?
|
Splenic Diseases | 1 | 1987 | 94 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 3 | 1991 | 212 | 0.020 |
Why?
|
Disaccharides | 1 | 1987 | 172 | 0.020 |
Why?
|
Sheep | 1 | 1989 | 1437 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 3 | 1993 | 1374 | 0.020 |
Why?
|
Serum Albumin | 1 | 1989 | 674 | 0.020 |
Why?
|
Acetylcysteine | 1 | 1987 | 272 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9639 | 0.020 |
Why?
|
Infant | 4 | 2003 | 35070 | 0.020 |
Why?
|
Infusions, Intravenous | 4 | 1993 | 2271 | 0.020 |
Why?
|
beta-Thromboglobulin | 1 | 2004 | 24 | 0.020 |
Why?
|
Postoperative Complications | 1 | 1987 | 15244 | 0.020 |
Why?
|
Anuria | 1 | 1984 | 15 | 0.020 |
Why?
|
Drug Stability | 1 | 1985 | 290 | 0.020 |
Why?
|
Cations | 1 | 1985 | 231 | 0.020 |
Why?
|
DNA Fingerprinting | 1 | 2004 | 112 | 0.020 |
Why?
|
Survival Analysis | 2 | 2012 | 10248 | 0.020 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 170 | 0.020 |
Why?
|
Prospective Studies | 3 | 2004 | 53187 | 0.020 |
Why?
|
Protein Binding | 3 | 1985 | 9387 | 0.020 |
Why?
|
Peritonitis | 2 | 2001 | 365 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 1993 | 4929 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 803 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 12164 | 0.010 |
Why?
|
Mezlocillin | 1 | 1982 | 3 | 0.010 |
Why?
|
Ceftizoxime | 1 | 1982 | 4 | 0.010 |
Why?
|
Azlocillin | 1 | 1982 | 19 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 2003 | 354 | 0.010 |
Why?
|
Chromosomes, Bacterial | 1 | 2004 | 282 | 0.010 |
Why?
|
Travel | 1 | 1989 | 788 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 1991 | 1067 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 829 | 0.010 |
Why?
|
Phenylalanine | 1 | 1984 | 365 | 0.010 |
Why?
|
United States | 4 | 2009 | 69693 | 0.010 |
Why?
|
Membranes | 1 | 1982 | 173 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2001 | 25575 | 0.010 |
Why?
|
Latex Fixation Tests | 1 | 2001 | 32 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1999 | 2837 | 0.010 |
Why?
|
Nucleotidyltransferases | 1 | 1984 | 220 | 0.010 |
Why?
|
Diarrhea | 1 | 1989 | 1343 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1991 | 1486 | 0.010 |
Why?
|
Carbon-Oxygen Ligases | 1 | 2001 | 4 | 0.010 |
Why?
|
Risk Factors | 5 | 2002 | 72145 | 0.010 |
Why?
|
Escherichia coli | 3 | 1994 | 4214 | 0.010 |
Why?
|
Transformation, Bacterial | 1 | 2001 | 78 | 0.010 |
Why?
|
Luciferases | 1 | 2003 | 733 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2003 | 585 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1982 | 1159 | 0.010 |
Why?
|
Endopeptidases | 1 | 2004 | 772 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 3 | 2001 | 20086 | 0.010 |
Why?
|
Trimethoprim Resistance | 1 | 2000 | 8 | 0.010 |
Why?
|
Chromosomes | 1 | 2003 | 595 | 0.010 |
Why?
|
Sequence Analysis | 1 | 2000 | 256 | 0.010 |
Why?
|
Gene Dosage | 1 | 2004 | 1251 | 0.010 |
Why?
|
Intubation | 1 | 2000 | 141 | 0.010 |
Why?
|
Peptide Synthases | 1 | 1999 | 80 | 0.010 |
Why?
|
Hydrolysis | 1 | 2000 | 682 | 0.010 |
Why?
|
Cell Membrane | 1 | 1989 | 3744 | 0.010 |
Why?
|
Sulfonamides | 1 | 1988 | 1932 | 0.010 |
Why?
|
Aged, 80 and over | 5 | 2004 | 57683 | 0.010 |
Why?
|
Immune Tolerance | 1 | 1987 | 2257 | 0.010 |
Why?
|
Acute Disease | 1 | 1989 | 7141 | 0.010 |
Why?
|
Mice | 2 | 2018 | 81045 | 0.010 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2004 | 1119 | 0.010 |
Why?
|
Data Collection | 1 | 1987 | 3339 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1985 | 1675 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 1999 | 468 | 0.010 |
Why?
|
Clostridium Infections | 1 | 1984 | 548 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7470 | 0.010 |
Why?
|
Bendroflumethiazide | 1 | 1975 | 1 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1999 | 810 | 0.010 |
Why?
|
Logistic Models | 2 | 2002 | 13403 | 0.010 |
Why?
|
Propylthiouracil | 1 | 1975 | 69 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9410 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4751 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1224 | 0.010 |
Why?
|
Colitis | 1 | 1983 | 1149 | 0.010 |
Why?
|
Genetic Testing | 1 | 2008 | 3439 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 1801 | 0.010 |
Why?
|
Pedigree | 1 | 2003 | 4646 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1999 | 2257 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1983 | 2231 | 0.010 |
Why?
|
Ribosomal Proteins | 2 | 1988 | 360 | 0.010 |
Why?
|
Bacteria, Aerobic | 1 | 1994 | 25 | 0.010 |
Why?
|
Morbidity | 1 | 2000 | 1767 | 0.010 |
Why?
|
Bacteria, Anaerobic | 1 | 1994 | 68 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21821 | 0.010 |
Why?
|
Ureaplasma urealyticum | 1 | 1993 | 38 | 0.010 |
Why?
|
Kidney | 2 | 1991 | 7167 | 0.010 |
Why?
|
Oncology Service, Hospital | 1 | 1992 | 57 | 0.010 |
Why?
|
Child | 1 | 2001 | 77478 | 0.010 |
Why?
|
Female Urogenital Diseases | 1 | 1993 | 52 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1987 | 3336 | 0.010 |
Why?
|
Trichomonas vaginalis | 1 | 1993 | 76 | 0.010 |
Why?
|
DNA Probes | 1 | 1993 | 560 | 0.010 |
Why?
|
Melanesia | 1 | 1991 | 18 | 0.010 |
Why?
|
Linear Models | 1 | 2002 | 5948 | 0.010 |
Why?
|
Candida | 1 | 1993 | 172 | 0.010 |
Why?
|
Delaware | 1 | 1991 | 16 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5867 | 0.010 |
Why?
|
Calcium | 1 | 1985 | 5753 | 0.010 |
Why?
|
Azithromycin | 1 | 1993 | 195 | 0.010 |
Why?
|
Virginia | 1 | 1991 | 121 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3420 | 0.010 |
Why?
|
Administration, Topical | 1 | 1993 | 688 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4742 | 0.010 |
Why?
|
Retrospective Studies | 4 | 2002 | 77098 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 1990 | 181 | 0.010 |
Why?
|
Regression Analysis | 1 | 2001 | 6452 | 0.010 |
Why?
|
Neutrophils | 1 | 2003 | 3711 | 0.010 |
Why?
|
Prednisone | 1 | 1975 | 1567 | 0.010 |
Why?
|
Philadelphia | 1 | 1991 | 263 | 0.010 |
Why?
|
Connecticut | 1 | 1991 | 363 | 0.010 |
Why?
|
Argentina | 1 | 1991 | 232 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1991 | 878 | 0.010 |
Why?
|
Lebanon | 1 | 1991 | 227 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2002 | 21719 | 0.010 |
Why?
|
Fresh Water | 1 | 1990 | 83 | 0.010 |
Why?
|
Texas | 1 | 1991 | 392 | 0.010 |
Why?
|
Campylobacter Infections | 1 | 1989 | 32 | 0.010 |
Why?
|
Child, Preschool | 3 | 2003 | 40955 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1989 | 156 | 0.010 |
Why?
|
Florida | 1 | 1991 | 435 | 0.010 |
Why?
|
Pennsylvania | 1 | 1991 | 613 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2001 | 3465 | 0.010 |
Why?
|
Benzothiazoles | 1 | 1990 | 247 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1989 | 517 | 0.010 |
Why?
|
Surgery Department, Hospital | 1 | 1990 | 175 | 0.010 |
Why?
|
Cohort Studies | 2 | 2002 | 40450 | 0.010 |
Why?
|
Pneumonia, Aspiration | 1 | 1990 | 144 | 0.010 |
Why?
|
Length of Stay | 1 | 2002 | 6294 | 0.010 |
Why?
|
Simplexvirus | 1 | 1993 | 802 | 0.010 |
Why?
|
Abdominal Muscles | 1 | 1989 | 162 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12242 | 0.010 |
Why?
|
Norfloxacin | 1 | 1988 | 25 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1975 | 1172 | 0.010 |
Why?
|
Boston | 2 | 1991 | 9305 | 0.000 |
Why?
|
Gastritis | 1 | 1989 | 191 | 0.000 |
Why?
|
Cerebral Arteries | 1 | 1990 | 492 | 0.000 |
Why?
|
Peptidoglycan | 1 | 1989 | 246 | 0.000 |
Why?
|
Risk | 1 | 1999 | 9679 | 0.000 |
Why?
|
Lactobacillus | 1 | 1987 | 189 | 0.000 |
Why?
|
Skilled Nursing Facilities | 1 | 1990 | 372 | 0.000 |
Why?
|
Monobactams | 1 | 1986 | 13 | 0.000 |
Why?
|
Rabbits | 1 | 1992 | 4886 | 0.000 |
Why?
|
Hospitals | 1 | 2000 | 3937 | 0.000 |
Why?
|
Random Allocation | 1 | 1990 | 2425 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1987 | 548 | 0.000 |
Why?
|
Survival Rate | 1 | 2000 | 12773 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1982 | 7873 | 0.000 |
Why?
|
Kinetics | 1 | 1993 | 6474 | 0.000 |
Why?
|
Creatinine | 1 | 1991 | 1916 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1986 | 637 | 0.000 |
Why?
|
Cerebral Angiography | 1 | 1990 | 1285 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1989 | 1372 | 0.000 |
Why?
|
Hospitals, Pediatric | 1 | 1992 | 1760 | 0.000 |
Why?
|
Adolescent | 2 | 2002 | 85649 | 0.000 |
Why?
|
Homosexuality | 1 | 1983 | 264 | 0.000 |
Why?
|
Aortic Valve | 1 | 1993 | 1911 | 0.000 |
Why?
|
Prevalence | 1 | 1999 | 15194 | 0.000 |
Why?
|
Cell Survival | 1 | 1992 | 5872 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1983 | 689 | 0.000 |
Why?
|
Signal Transduction | 1 | 2003 | 23387 | 0.000 |
Why?
|
Cytomegalovirus | 1 | 1983 | 730 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1990 | 10943 | 0.000 |
Why?
|
Massachusetts | 1 | 1990 | 8662 | 0.000 |
Why?
|
Pediatrics | 1 | 1990 | 3462 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 1992 | 19862 | 0.000 |
Why?
|
Phosphorylation | 1 | 1985 | 8436 | 0.000 |
Why?
|
Hospitalization | 1 | 1992 | 10232 | 0.000 |
Why?
|
Prognosis | 1 | 1991 | 29010 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1986 | 7901 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1983 | 9274 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1983 | 10163 | 0.000 |
Why?
|
Lung | 1 | 1983 | 9826 | 0.000 |
Why?
|